Why Desametasone Sodio Fosfato + Tobramicina is in shortage
manufacturing problems — e.g. “Problemi produttivi (carenza relativa solo al canale ospedaliero)” (Italy)
unexpected increases in demand
— e.g. “Elevata richiesta: distribuzione contingentata” (Italy)
causes not stated by the regulator — e.g. “Problemi regolatori” (Italy)
Recent shortage history
Italy: resolved 1 Sept 2025 (began 1 Sept 2025)
Italy: resolved 9 Jun 2025 (began 9 Jun 2025)
Italy: resolved 30 Apr 2025 (began 30 Apr 2025)
Italy: resolved 7 Feb 2025 (began 7 Feb 2025)
Italy: resolved 31 May 2023 (began 31 May 2023)
Italy: resolved 30 Nov 2021 (began 30 Nov 2021)
Italy: resolved 15 Oct 2021 (began 15 Oct 2021)
Italy: resolved 15 Jul 2021 (began 15 Jul 2021)
Frequently asked questions
Is Desametasone Sodio Fosfato + Tobramicina currently in shortage?
Yes. As of the latest regulator updates, Desametasone Sodio Fosfato + Tobramicina has 10 active shortage notices across 1 country (Italy). Status is refreshed daily from official regulatory sources.
Why is Desametasone Sodio Fosfato + Tobramicina in shortage?
Regulators attribute the current Desametasone Sodio Fosfato + Tobramicina shortages to manufacturing problems, unexpected increases in demand, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Desametasone Sodio Fosfato + Tobramicina shortage be resolved?
Regulator-estimated resolution dates currently range from 1 Dec 2026 to 31 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Desametasone Sodio Fosfato + Tobramicina shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Desametasone Sodio Fosfato + Tobramicina status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.